The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics.

Cold Spring Harbor Perspectives in Medicine
Ute I SchwarzRichard B Kim

Abstract

Inherited genetic variations in pharmacogenetic loci are widely acknowledged as important determinants of phenotypic differences in drug response, and may be actionable in the clinic. However, recent studies suggest that a considerable number of novel rare variants in pharmacogenes likely contribute to a still unexplained fraction of the observed interindividual variability. Next-generation sequencing (NGS) represents a rapid, relatively inexpensive, large-scale DNA sequencing technology with potential relevance as a comprehensive pharmacogenetic genotyping platform to identify genetic variation related to drug therapy. However, many obstacles remain before the clinical use of NGS-based test results, including technical challenges, functional interpretation, and strict requirements for diagnostic tests. Advanced computational analyses, high-throughput screening methodologies, and generation of shared resources with cell-based and clinical information will facilitate the integration of NGS data into candidate genotyping approaches, likely enhancing future drug phenotype predictions in patients.

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Nov 2, 1995·The New England Journal of Medicine·P J BosmaR P Oude Elferink
Oct 27, 2001·British Journal of Clinical Pharmacology·M Pirmohamed
Jun 20, 2003·The Pharmacogenomics Journal·C Guillemette
Apr 30, 2004·Clinical Pharmacology and Therapeutics·Jessica MwinyiThomas Gerloff
May 29, 2004·Pharmacogenetics·Rebecca L BlanchardMichael W H Coughtrie
Oct 22, 2004·Nature·UNKNOWN International Human Genome Sequencing Consortium
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·John D HayesIan R Jowsey
Sep 20, 2005·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Simon SandersonJon Emery
Jul 25, 2008·The New England Journal of Medicine·UNKNOWN SEARCH Collaborative GroupR Collins
Jul 11, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anne T NiesElke Schaeffeler
Sep 30, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marianne K DeGorter, Richard B Kim
Oct 20, 2009·Current Pharmaceutical Design·R M FrankeA Sparreboom
Jan 30, 2010·Nature Methods·Lira MamanovaDaniel J Turner
Mar 20, 2010·Nature Reviews. Genetics·Ann K Daly
Apr 1, 2010·Nature Methods·Ivan A AdzhubeiShamil R Sunyaev
Jul 20, 2010·Pharmacogenetics and Genomics·Alison A Motsinger-ReifDan M Roden
Nov 10, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Curtis J OmiecinskiJeffrey M Peters
Nov 18, 2010·Clinical Pharmacology and Therapeutics·L J LeskoS-M Huang
Jan 29, 2011·Clinical Pharmacology and Therapeutics·M V RellingUNKNOWN Clinical Pharmacogenetics Implementation Consortium
May 19, 2011·Nature Reviews. Genetics·Rasmus NielsenYun S Song
Jul 1, 2011·Clinical Pharmacology and Therapeutics·S A ScottUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Sep 9, 2011·Clinical Pharmacology and Therapeutics·J A JohnsonUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Sep 17, 2011·Nature Reviews. Genetics·Sharon R Browning, Brian L Browning
Sep 29, 2011·Annual Review of Pharmacology and Toxicology·M K DeGorterR B Kim
Oct 22, 2011·International Journal of Molecular Sciences·Alice C RodriguesRosario D C Hirata
May 19, 2012·Science·Jacob A TennessenUNKNOWN NHLBI Exome Sequencing Project
Jul 31, 2012·Trends in Genetics : TIG·Ashraf G MadianM Eileen Dolan
Sep 7, 2012·Genome Biology·Baikang PeiMark B Gerstein

❮ Previous
Next ❯

Citations

Feb 16, 2019·Genome Medicine·Charles AuffrayMatthias Schwab
Sep 13, 2019·Expert Opinion on Drug Metabolism & Toxicology·Giuseppe MiscioDavide Seripa
Jun 5, 2019·BMC Medical Genomics·Markus GulilatUte I Schwarz
Oct 22, 2019·Frontiers in Public Health·Dora Il'yasova, Alexander V Kinev
Apr 25, 2020·Scientific Reports·José A G AgúndezInmaculada Andreu
Mar 19, 2020·Pharmacogenomics and Personalized Medicine·Carlos Alberto Calderon-OspinaDora Janeth Fonseca Mendoza
Apr 3, 2020·High-throughput·Giuseppe AgapitoMaria Teresa Di Martino
Mar 21, 2020·Horticulture Research·Vance M WhitakerSujeet Verma
Oct 3, 2020·Annual Review of Pharmacology and Toxicology·Wan-Chun ChangBruce C Carleton
Jan 14, 2020·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·A ToliosT Mohr
Sep 4, 2020·Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology·Juan WangLixia Lu
Mar 16, 2021·Horticulture Research·Vance M WhitakerSujeet Verma
Jun 7, 2021·Human Genomics·Kariofyllis KaramperisGeorge P Patrinos
Oct 8, 2021·Neuron·Antonio F PardiñasJames T R Walters
Nov 4, 2021·Expert Opinion on Drug Metabolism & Toxicology·Denise TürkThorsten Lehr

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.